Journal Scans
Salvage Chemotherapy With Alternating MINE–ESHAP Regimen in Relapsed or Refractory Hodgkin's Lymphoma Followed by Autologous Stem-Cell Transplantation
MINE-ESHAP as Salvage Therapy in Relapsed/Refractory Hodgkin's Lymphoma
C Fernández de Larrea, C Martínez, A Gaya, A López-Guillermo, M Rovira, F Fernández-Avilés, M Lozano, F Bosch, J Esteve, B Nomdedeu, E Montserrat, E Carreras
20100501
2010 Jun 1
Ann Oncol
Salvage Chemotherapy With Alternating MINE–ESHAP Regimen in Relapsed or Refractory Hodgkin's Lymphoma Followed by Autologous Stem-Cell Transplantation
Ann Oncol. 2010 Jun 1;[Epub Ahead of Print], C Fernández de Larrea, C Martínez, A Gaya, A López-Guillermo, M Rovira, F Fernández-Avilés, M Lozano, F Bosch, J Esteve, B Nomdedeu, E Montserrat, E Carreras
TAKE-HOME MESSAGE
Abstract
SUMMARY
OncologySTAT Editorial Team
The gold standard for patients with relapsed/refractory Hodgkin’s lymphoma (HL) is high-dose chemotherapy (HDT) followed by autologous stem-cell transplantation (ASCT). The best pretransplantation salvage chemotherapy regimen would combine therapeutic activity, stem-cell mobilizing potential, and low toxicity. However, the optimal salvage regimen has not been identified through randomized trials. Researchers from Barcelona retrospectively reviewed 61 relapsed/refractory HL cases treated from 2000...
